Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Read now
Inês Tabarra, Sofia Soares, Tiago Rosado, Joana Gonçalves, Ângelo Luís, Sara Malaca, Mário Barroso, Thomas Keller, José Restolho & Eugenia Gallardo. (2019) Novel synthetic opioids – toxicological aspects and analysis. Forensic Sciences Research 4:2, pages 111-140.
Read now
Read now
Olaf H. Drummer. (2019) Fatalities caused by novel opioids: a review. Forensic Sciences Research 4:2, pages 95-110.
Read now
Read now
Charles R Caffrey & Patrick M Lank. (2018) When good times go bad: managing ‘legal high’ complications in the emergency department. Open Access Emergency Medicine 10, pages 9-23.
Read now
Read now
Anders Helander, Matilda Bäckberg, Patrick Signell & Olof Beck. (2017) Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project. Clinical Toxicology 55:6, pages 589-599.
Read now
Read now
Anders Helander & Matilda Bäckberg. (2017) New Psychoactive Substances (NPS) – the Hydra monster of recreational drugs. Clinical Toxicology 55:1, pages 1-3.
Read now
Read now
Aaron Schneir, Imir G. Metushi, Christian Sloane, David J. Benaron & Robert L. Fitzgerald. (2017) Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class. Clinical Toxicology 55:1, pages 51-54.
Read now
Read now
Matilda Bäckberg, Jenny Westerbergh, Olof Beck & Anders Helander. (2016) Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project. Clinical Toxicology 54:9, pages 819-825.
Read now
Read now
Olof Beck, Lisa Franzén, Matilda Bäckberg, Patrick Signell & Anders Helander. (2016) Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clinical Toxicology 54:7, pages 568-575.
Read now
Read now
Anders Helander, Matilda Bäckberg & Olof Beck. (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clinical Toxicology 54:4, pages 324-332.
Read now
Read now
Derrick Lung, Nathan Wilson, Francois-Thibaut Chatenet, Clemence LaCroix & Roy Gerona. (2016) Non-targeted screening for novel psychoactive substances among agitated emergency department patients. Clinical Toxicology 54:4, pages 319-323.
Read now
Read now
Olof Beck, Lisa Franzen, Matilda Bäckberg, Patrick Signell & Anders Helander. (2015) Intoxications involving MDPV in Sweden during 2010–2014: Results from the STRIDA project. Clinical Toxicology 53:9, pages 865-873.
Read now
Read now
Matilda Bäckberg, Olof Beck & Anders Helander. (2015) Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clinical Toxicology 53:9, pages 856-864.
Read now
Read now
Matilda Bäckberg, Olof Beck, Karl-Henrik Jönsson & Anders Helander. (2015) Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clinical Toxicology 53:7, pages 609-617.
Read now
Read now
Anders Helander, Olof Beck & Matilda Bäckberg. (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clinical Toxicology 53:5, pages 446-453.
Read now
Read now
Sindhu Siddiqi, Charlotte Verney, Paul Dargan & David M. Wood. (2015) Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology 53:1, pages 54-59.
Read now
Read now
Articles from other publishers (64)
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta & Jakub Wojcieszak. (2023) Non-fentanyl new synthetic opioids – An update. Forensic Science International 349, pages 111775.
Crossref
Crossref
Michalina Zaborowska, Michał A. Dobrowolski & Dorota Matyszewska. (2023) Revealing the structure and mechanisms of action of a synthetic opioid with model biological membranes at the air-water interface. Colloids and Surfaces B: Biointerfaces 226, pages 113289.
Crossref
Crossref
Sabrine Bilel, Arianna Giorgetti, Micaela Tirri, Raffaella Arfè, Virginia Cristofori, Beatrice Marchetti, Giorgia Corli, Lorenzo Caruso, Giorgio Zauli, Raffaele Giorgetti & Matteo Marti. (2023) Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice:
Possible Impact on Human Driving Performances. Current Neuropharmacology 21:1, pages 87-104.
Crossref
Crossref
Donna M. Papsun, Alex J. Krotulski & Barry K. Logan. (2022) Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. American Journal of Forensic Medicine & Pathology 43:4, pages 315-327.
Crossref
Crossref
Shane Darke, Amy Peacock, Johan Duflou, Michael Farrell & Julia Lappin. (2022) Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia. Drug and Alcohol Dependence 232, pages 109292.
Crossref
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2022) Synthetic opioids: a review and clinical update. Therapeutic Advances in Psychopharmacology 12, pages 204512532211396.
Crossref
Crossref
Michelle L. Hughes, Amanda I. Rodriguez, Jonathan Hatch & Kenneth Zoucha. (2022) Hearing and Vestibular Loss with Misuse of Opioids and Illicit Drugs: A Review of the Literature. Audiology and Neurotology 27:4, pages 271-281.
Crossref
Crossref
Vincenzo Abbate, Andrea Sosa Moreno & Timothy J. Wiegand. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
447
474
.
Piotr Adamowicz & Karolina Nowak. (2021) Blood concentrations of new synthetic opioids. International Journal of Legal Medicine 136:1, pages 107-122.
Crossref
Crossref
David Vearrier & Oliver Grundmann. (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. The Journal of Clinical Pharmacology 61:S2.
Crossref
Crossref
Michal Ordak, Aleksandra Zmysłowska, Miłosz Bielski, Daniel Rybak, Maja Tomaszewska, Katarzyna Wyszomierska, Aleksandra Kmiec, Natalia Garlicka, Maria Zalewska, Michal Zalewski, Tadeusz Nasierowski, Elzbieta Muszynska & Magdalena Bujalska-Zadrozny. (2021) Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports. Frontiers in Psychiatry 12.
Crossref
Crossref
Annelies Cannaert, Fabian Hulpia, Martijn Risseeuw, Katleen Van Uytfanghe, Eric Deconinck, Serge Van Calenbergh, Peter Blanckaert & Christophe Stove. (2021)
Report on a New Opioid NPS: Chemical and
In Vitro
Functional Characterization of a Structural Isomer of the MT-45 Derivative Diphenpipenol
. Journal of Analytical Toxicology 45:2, pages 134-140.
Crossref
Crossref
Oliwia Frączak, Kinga Kądzioła-Długołęcka, Ilona Kijewska, Radosław Wilczek, Beata Tkacz-Szczęsna, Krzysztof Makowski, Piotr Komorowski, Robert Bachliński, Anna Trynda & Bogdan Walkowiak. (2020) Raman spectroscopy and gas chromatography with flame ionization detection as analysis tools in stability tests of selected synthetic psychoactive substances: 5-IT, MT-45 and 4-CMC. Vibrational Spectroscopy 111, pages 103176.
Crossref
Crossref
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
307
325
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Daniel T. Baptista‐Hon, Mark Smith, Samuel Singleton, Lysbeth H. Antonides, Niamh Nic Daeid, Craig McKenzie & Tim G. Hales. (2020)
Activation of μ‐opioid receptors by
MT‐45
(1‐cyclohexyl‐4‐(1,2‐diphenylethyl)piperazine) and its fluorinated derivatives
. British Journal of Pharmacology 177:15, pages 3436-3448.
Crossref
Crossref
S Bilel, NJ Azevedo, R Arfè, M Tirri, A Gregori, G Serpelloni, F De-Giorgio, P Frisoni, M Neri, G Calò & M Marti. (2020) In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45. Neuropharmacology 171, pages 108110.
Crossref
Crossref
Anders Helander, Matilda Bäckberg & Olof Beck. (2020) Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLOS ONE 15:4, pages e0232038.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Sophie Salle, Sandra Bodeau, Alice Dhersin, Mathilde Ferdonnet, Ruben Goncalves, Marie Lenski, Benjamin Lima, Marie Martin, Jonathan Outreville, Jules Vaucel & Nicolas Fabresse. (2019) Novel synthetic opioids: A review of the literature. Toxicologie Analytique et Clinique 31:4, pages 298-316.
Crossref
Crossref
Jean-Michel Gaulier, Camille Richeval, Mélodie Phanithavong, Sandrine Brault, Delphine Allorge & Véronique Dumestre-Toulet. (2019) A case report of carfentanil-related fatality in France. Toxicologie Analytique et Clinique 31:4, pages 323-331.
Crossref
Crossref
Paul J Jannetto, Anders Helander, Uttam Garg, Gregory C Janis, Bruce Goldberger & Hemamalini Ketha. (2019) The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry 65:2, pages 242-253.
Crossref
Crossref
Barbara Lovrecic, Mercedes Lovrecic, Branko Gabrovec, Marco Carli, Matteo Pacini, Angelo G. I. Maremmani & Icro Maremmani. (2019) Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health. International Journal of Environmental Research and Public Health 16:2, pages 177.
Crossref
Crossref
Olof Beck, Alexia Rylski & Niclas Nikolai Stephanson. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing
321
332
.
Kirti Kumari Sharma, Tim G. Hales, Vaidya Jayathirtha Rao, Niamh NicDaeid & Craig McKenzie. (2018) The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning. Forensic Toxicology 37:1, pages 1-16.
Crossref
Crossref
Michael T Truver & Madeleine J Swortwood. (2018) Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC–MS-MS. Journal of Analytical Toxicology 42:8, pages 554-561.
Crossref
Crossref
Paolo Frisoni, Erica Bacchio, Sabrine Bilel, Anna Talarico, Rosa Gaudio, Mario Barbieri, Margherita Neri & Matteo Marti. (2018) Novel Synthetic Opioids: The Pathologist’s Point of View. Brain Sciences 8:9, pages 170.
Crossref
Crossref
Anders Helander, Katarina Stojanovic, Tomas Villén & Olof Beck. (2018) Detectability of fentanyl and designer fentanyls in urine by 3 commercial fentanyl immunoassays. Drug Testing and Analysis 10:8, pages 1297-1304.
Crossref
Crossref
Craig McKenzie, Oliver B. Sutcliffe, Kevin D. Read, Paul Scullion, Ola Epemolu, Daniel Fletcher, Anders Helander, Olof Beck, Alexia Rylski, Lysbeth H. Antonides, Jennifer Riley, Shannah A. Smith & Niamh Nic Daeid. (2018) Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users. Forensic Toxicology 36:2, pages 359-374.
Crossref
Crossref
Renata Solimini, Simona Pichini, Roberta Pacifici, Francesco P. Busardò & Raffaele Giorgetti. (2018) Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids. Frontiers in Pharmacology 9.
Crossref
Crossref
Patil Armenian, Kathy T. Vo, Jill Barr-Walker & Kara L. Lynch. (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology 134, pages 121-132.
Crossref
Crossref
Michael H. Baumann, Susruta Majumdar, Valerie Le Rouzic, Amanda Hunkele, Rajendra Uprety, Xi Ping Huang, Jin Xu, Bryan L. Roth, Ying-Xian Pan & Gavril W. Pasternak. (2018) Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace. Neuropharmacology 134, pages 101-107.
Crossref
Crossref
Matilda Bäckberg, Karl-Henrik Jönsson, Olof Beck & Anders Helander. (2018) Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Testing and Analysis 10:2, pages 340-349.
Crossref
Crossref
Patrick M. Beardsley & Yan Zhang. 2018. New Psychoactive Substances. New Psychoactive Substances
353
381
.
Anders Helander & Matilda Bäckberg. 2018. New Psychoactive Substances. New Psychoactive Substances
461
473
.
Lea Wagmann & Hans H. Maurer. 2018. New Psychoactive Substances. New Psychoactive Substances
413
439
.
Camilla Montesano, Gabriele Vannutelli, Federico Fanti, Flaminia Vincenti, Adolfo Gregori, Anna Rita Togna, Isabella Canazza, Matteo Marti & Manuel Sergi. (2017) Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation. Journal of Analytical Toxicology 41:8, pages 688-697.
Crossref
Crossref
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Crossref
A. Helander, M. Bradley & J. Lapins. (2017) ‘Is nitrogen mustard contamination responsible for the reported MT-45 toxicity?’ Reply from the authors. British Journal of Dermatology 177:2, pages 595-595.
Crossref
Crossref
L. Yip & J.-F. Deng. (2017) Adulterant or contaminant in MT-45, or coingestion?. British Journal of Dermatology 177:2, pages 582-582.
Crossref
Crossref
Helena Fels, Julia Krueger, Hans Sachs, Frank Musshoff, Matthias Graw, Gabriele Roider & Andreas Stoever. (2017) Two fatalities associated with synthetic opioids: AH-7921 and MT-45. Forensic Science International 277, pages e30-e35.
Crossref
Crossref
D. Fabregat-Safont, X. Carbón, M. Ventura, I. Fornís, E. Guillamón, J. V. Sancho, F. Hernández & M. Ibáñez. (2017) Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900). Scientific Reports 7:1.
Crossref
Crossref
Matthew P. Prekupec, Peter A. Mansky & Michael H. Baumann. (2017) Misuse of Novel Synthetic Opioids: A Deadly New Trend. Journal of Addiction Medicine 11:4, pages 256-265.
Crossref
Crossref
Jolanta B. Zawilska. (2017) An Expanding World of Novel Psychoactive Substances: Opioids. Frontiers in Psychiatry 8.
Crossref
Crossref
Melissa M. Goggin, An Nguyen & Gregory C. Janis. (2017) Identification of Unique Metabolites of the Designer Opioid Furanyl Fentanyl. Journal of Analytical Toxicology 41:5, pages 367-375.
Crossref
Crossref
Anders Helander. 2017. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation
83
99
.
A. Helander, M. Bradley, A. Hasselblad, L. Norlén, I. Vassilaki, M. Bäckberg & J. Lapins. (2017) Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. British Journal of Dermatology 176:4, pages 1021-1027.
Crossref
Crossref
Marcin Rojkiewicz, Milena Majchrzak, Rafał Celiński, Piotr Kuś & Mieczysław Sajewicz. (2017) Identification and physicochemical characterization of 4-fluorobutyrfentanyl (1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one, 4-FBF) in seized materials and post-mortem biological samples. Drug Testing and Analysis 9:3, pages 405-414.
Crossref
Crossref
Amanda L. A. Mohr, Melissa Friscia, Donna Papsun, Sherri L. Kacinko, David Buzby & Barry K. Logan. (2016) Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC–MS/MS in Postmortem Casework. Journal of Analytical Toxicology.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
208
218
.
Simon Elliott. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
94
126
.
Markus R. Meyer & Hans H. Maurer. (2016) Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices – Where do we stand today?. Analytica Chimica Acta 927, pages 13-20.
Crossref
Crossref
Jason Wallach, Heather Kang, Tristan Colestock, Hamilton Morris, Zuner A. Bortolotto, Graham L. Collingridge, David Lodge, Adam L. Halberstadt, Simon D. Brandt & Adeboye Adejare. (2016) Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and Analogues. PLOS ONE 11:6, pages e0157021.
Crossref
Crossref
Donna Papsun, Alison Krywanczyk, James C. Vose, Elizabeth A. Bundock & Barry K. Logan. (2016) Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC–MS-MS and Its Identification in a Drug-Related Death. Journal of Analytical Toxicology 40:4, pages 313-317.
Crossref
Crossref
Markus R. Meyer, Madeleine Pettersson Bergstrand, Anders Helander & Olof Beck. (2016) Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Analytical and Bioanalytical Chemistry 408:13, pages 3571-3591.
Crossref
Crossref
Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Astrid Gjelstad & Ritva Karinen. (2016) Oral fluid drug analysis in the age of new psychoactive substances. Bioanalysis 8:7, pages 691-710.
Crossref
Crossref
Colin Davidson & Fabrizio Schifano. (2016) The potential utility of some legal highs in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 267-274.
Crossref
Crossref
Richard J. Bodnar. (2016) Endogenous opiates and behavior: 2014. Peptides 75, pages 18-70.
Crossref
Crossref
Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, John O'Brien, Brian Talbot, Simon P. Elliott, Jason Wallach, Khoa Hoang, Hamilton Morris & Simon D. Brandt. (2016)
Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its
meta
- and
para
-substituted isomers
. Drug Testing and Analysis 8:1, pages 98-109.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
Fabrizio Schifano. (2015) Novel psychoactive substances (NPS): clinical and pharmacological issues. Drugs and Alcohol Today 15:1, pages 21-27.
Crossref
Crossref
Fabrizio Schifano, Laura Orsolini, G. Duccio Papanti & John M. Corkery. (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:1, pages 15-26.
Crossref
Crossref